Download PDF
Exp Clin Endocrinol Diabetes 2005; 113(1): 38-42
DOI: 10.1055/s-2004-830525
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Gastric Electrical Stimulation Results in Improved Metabolic Control in Diabetic Patients Suffering From Gastroparesis

I. R. van der Voort1 , 2 , J. C. Becker3 , K. H. Dietl4 , J. W. Konturek5 , W. Domschke3 , T. Pohle3
  • 1Department of Internal Medicine, Division of Hepatology and Gastroenterology, Charité, Campus Virchow Klinikum, Humboldt-University Berlin, Berlin, Germany
  • 2Department of Internal Medicine, Division of Psychosomatic Medicine and Psychotherapy, Charité, Campus Charité Mitte, Humboldt-University Berlin, Berlin, Germany
  • 3Department of Medicine B, University of Münster, Münster, Germany
  • 4Department of Surgery, Raphaelsklinik, Münster, Germany
  • 5Department of Medicine/Gastroenterology, Elbe-Klinikum Stade, Stade, Germany
Further Information

Publication History

Received: February 4, 2004 First decision: April 2, 2004

Accepted: May 3, 2004

Publication Date:
21 January 2005 (online)

Also available at
    Permissions and Reprints

Abstract

Aims/hypothesis: Symptoms of gastroparesis possess a heavy impact on the quality of life; delayed gastric emptying may result in poor metabolic control in diabetics. Gastric electrical stimulation (GES) has recently been introduced as a treatment option in patients with drug refractory gastroparesis to increase the quality of life by alleviating nausea and vomiting frequencies. However, the effect of GES on metabolic control has not been assessed yet.

Methods: We performed a prospective single center study on the long-term effect (12 months) of continuous high-frequency/low-energy GES on symptoms, gastric emptying (measured scintigraphically), and metabolic control (HbA1c) in insulin-dependent diabetic subjects suffering from drug-refractory gastroparesis for more than one year.

Results: Seventeen (12 female, 5 male) patients entered the study; all were available for analysis at all time points. No therapy-associated adverse events occurred. Weekly vomiting and nausea frequencies decreased significantly at 6 and 12 months. Gastric retention rates improved significantly from 83 % (2 h) and 38 % (4 h) to 35 % (2 h)/14 % (4 h) and 25 % (2 h)/17 % (4 h) at 6 and 12 months, respectively. HbA1c values were lowered in all 17 subjects; initially, all HbA1c values were above 7.5 %; at 6 and 12 months, mean values had significantly decreased from 8.6 % to 6.2 % and 6.5 %, respectively.

Conclusions/interpretation: Gastric electrical stimulation offers symptom control in diabetics with drug-refractory gastroparesis and decreases gastric retention. This study, for the first time, documents a positive effect of this therapy on metabolic control as indicated by HbA1c, a surrogate marker of the risk of diabetic complications.

Key words

Diabetes - gastroparesis - gastric electrical stimulation - glycohemoglobin - HbA1c

References

  • 1 Abell T L, Van Cutsem E, Abrahamsson H, Huizinga J D, Konturek J W, Galmiche J P, Voeller G, Filez L, Everts B, Waterfall W E, Domschke W, Bruley des Varranes S, Familoni B O, Bourgeois I M, Janssens J, Tougas G. Gastric electrical stimulation in intractable symptomatic gastroparesis.  Digestion. 2002;  66 204-212
    CrossrefPubMedGoogle Scholar
  • 2 Abell T L, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, Lindberg G, Konturek J, Nowak T, Quigley E M, Tougas G, Starkebaum W. Gastric electrical stimulation for medically refractory gastroparesis.  Gastroenterology. 2003 a;  125 421-428
    CrossrefPubMedGoogle Scholar
  • 3 Abell T, Lou J, Tabbaa M, Batista O, Malinowski S, Al-Juburi A. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up.  JPEN J Parenter Enteral Nutr. 2003 b;  27 277-281
    PubMedGoogle Scholar
  • 4 American Diabetes Association (ADA) . Clinical practice recommendations 2000.  Diabetes Care. 2000;  23 (Suppl 1) S1-116
    PubMedGoogle Scholar
  • 5 Becker J C, Dietl K H, Konturek J W, Domschke W, Pohle T. Gastric wall perforation - a rare complication of gastric electrical stimulation.  Gastrointest Endosc. 2004;  59 584-586
    CrossrefPubMedGoogle Scholar
  • 6 Bilgutay A M, Wingrove R, Griffen W O, Bonnabeau R C, Lillehei C W. Gastrointestinal pacing: A new concept in treatment of ileus.  Ann Surg. 1963;  158 338-347
    PubMedGoogle Scholar
  • 7 Bortolotti M. The “electrical way” to cure gastroparesis.  Am J Gastroenterol. 2002;  97 1874-1883
    PubMedGoogle Scholar
  • 8 Braden B, Enghofer M, Schaub M, Usadel K H, Caspary W F, Lembcke B. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control.  Aliment Pharmacol Ther. 2002;  16 1341-1346
    CrossrefPubMedGoogle Scholar
  • 9 De Block C E, De Leeuw I H, Pelckmans P A, Callens D, Maday E, Van Gaal L F. Delayed gastric emptying and gastric autoimmunity in type 1 diabetes.  Diabetes Care. 2002;  25 912-917
    PubMedGoogle Scholar
  • 10 The Diabetes Control and Complications Trial (DCCT) Research Groups . The effect of intensive treatment of diabetes in the development and progression of long-term complications in insulin-dependent diabetes mellitus.  N Engl J Med. 1993;  329 977-986
    Google Scholar
  • 11 Horowitz M, Maddox A, Harding P E, Maddern G J, Chatterton B E, Wishart J, Shearman D J. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus.  Gastroenterology. 1987;  92 1899-1907
    PubMedGoogle Scholar
  • 12 Ishiguchi T, Tada H, Nakagawa K, Yamamura T, Takahashi T. Hyperglycemia impairs antro-pyloric coordination and delays gastric emptying in conscious rats.  Auton Neurosci. 2002;  95 112-120
    PubMedGoogle Scholar
  • 13 Jones M P, Maganti K. A systematic review of surgical therapy for gastroparesis.  Am J Gastroenterol. 2003;  98 2122-2129
    CrossrefPubMedGoogle Scholar
  • 14 Krishnamurti U, Steffes M W. Glycohemoglobin: a primary predictor of the development or reversal of complications of diabetes mellitus.  Clin Chem. 2001;  47 1157-1165
    PubMedGoogle Scholar
  • 15 Lin Z, Forster J, Sarosiek I, McCallum R W. Treatment of gastroparesis with electrical stimulation.  Dig Dis Sci. 2003;  48 837-848
    CrossrefPubMedGoogle Scholar
  • 16 McCallum R W, Lin Z, Olyaee M, Sarosiek I, Forster J. High-frequency electrical stimulation of the stomach for the treatment of gastroparesis (abstract).  Neurogastroenterol Motil. 2000;  12 488
    PubMedGoogle Scholar
  • 17 Petrakis I E, Kogerakis N, Prokopakis G, Zacharioudakis G, Antonakakis S, Vrachassotakis N, Chalkiadakis G. Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects.  Dig Dis Sci. 2002;  47 67-72
    CrossrefPubMedGoogle Scholar
  • 18 Rabine J C, Barnett J L. Management of patients with gastroparesis.  J Clin Gastroenterol. 2001;  32 11-18
    CrossrefPubMedGoogle Scholar
  • 19 Soykan I, Sarosiek I, McCallum R W. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.  Am J Gastroenterol. 1997;  92 976-980
    PubMedGoogle Scholar
  • 20 Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum R W. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.  Dig Dis Sci. 1998;  43 2398-2404
    CrossrefPubMedGoogle Scholar
  • 21 Tougas G, Eaker E Y, Abell T L, Abrahamsson H, Boivin M, Chen J, Hocking M P, Quigley E M, Koch K L, Tokayer A Z, Stanghellini V, Chen Y, Huizinga J D, Ryden J, Bourgeois I, McCallum R W. Assessment of gastric emptying using a low fat meal: establishment of international control values.  Am J Gastroenterol. 2000;  95 1456-1462
    CrossrefPubMedGoogle Scholar

MD Thorsten Pohle

Department of Medicine B
University of Münster

48129 Münster

Germany

Phone: + 492518347559

Fax: + 49 25 18 34 95 04

Email: pohlet@uni-muenster.de

      >